查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016159

单核苷酸多态性（SNP）基因型鉴定市场报告：按技术、应用和地区划分（2026-2034 年）

Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

全球单核苷酸多态性（SNP）基因型鉴定市场在2025年达到130亿美元。 IMARC集团预测，到2034年，该市场将达到452亿美元，2026年至2034年的复合年增长率（CAGR）为14.41%。市场成长的主要驱动因素包括与基因分型相关的研发活动的扩大、对个人化医疗和新型药物递送系统的需求不断增长，以及对动植物材料基因分析的需求不断增长。

单核苷酸多态性（SNP）基因型鉴定是一种透过检测去氧核糖核酸（DNA）序列中的特定位点来识别和分析个体间遗传变异的技术。它涉及识别个体DNA中特定SNP位点存在的特定核苷酸。此方法依赖聚合酵素链锁反应（PCR）和DNA定序等先进的分子生物学技术。具体而言，PCR扩增含有SNP的DNA片段，然后透过直接定序扩增的DNA或使用其他方法（例如微阵列或等位基因特异性PCR）来识别SNP位点的核苷酸。这有助于理解群体遗传学、迁移模式和演化历史。它在确定药物反应性、预测疾病易感性以及开发针对特定基因型的治疗方法方面也发挥着至关重要的作用。研究人员利用SNP基因型鉴定来阐明复杂疾病的遗传基础、识别遗传风险因子并开发先进的诊断工具。

单核苷酸多态性（SNP）基因型鉴定市场趋势：

目前，SNP基因型鉴定需求的不断增长正在推动市场成长，这主要得益于基因分型研发活动的日益活跃以及生物资讯学在诊断工具和各种疾病有效治疗方法开发中的应用。此外，SNP基因型鉴定在阐明癌症、心血管疾病、阿兹海默症和气喘等多种人类疾病的发病机制方面的应用不断扩展，也为市场带来了良好的前景。同时，全球对SNP基因型鉴定的需求也不断增长，用于建立遗传关係、解决亲子鑑定纠纷以及支持刑事调查。这些需求与蓬勃发展的医疗产业共同推动了市场成长。此外，个人化医疗和新型药物递送系统研发管线的扩展也带动了药物基因体学需求的成长，进一步促进了市场成长。生命科学领域众多SNP基因型鉴定技术的应用，包括农业生物技术、诊断研究、製药、药物药物基因体学学以及动物和牲畜育种等，也为市场成长做出了贡献。全球范围内糖尿病、心血管疾病和癌症发病率的不断上升也对市场产生了积极影响。此外，对动植物饲料原料进行基因分析的需求日益增长，也推动了市场成长。

本报告解答的主要问题

  • 全球单核苷酸多态性（SNP）基因型鉴定市场迄今的发展轨迹如何？未来几年预计会出现哪些趋势？
  • 全球单核苷酸多态性（SNP）基因型鉴定市场的市场驱动因素、限制因素和机会是什么？
  • 影响全球单核苷酸多态性（SNP）基因型鉴定市场的驱动因素、限制因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪个国家的单核苷酸多态性（SNP）基因型鉴定市场最具吸引力？
  • 市场按技术划分是怎样的？
  • 在单核苷酸多态性（SNP）基因型鉴定市场中，哪种技术最具吸引力？
  • 按应用领域分類的市场区隔如何？
  • 单核苷酸多态性（SNP）基因型鉴定市场中最具吸引力的应用有哪些？
  • 全球单核苷酸多态性（SNP）基因型鉴定市场的竞争格局如何？
  • 全球单核苷酸多态性（SNP）基因型鉴定市场的主要参与者/公司有哪些？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球单核苷酸多态性（SNP）基因型鉴定市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依技术划分

  • TaqMan SNP基因基因型鉴定
  • Massarray SNP基因型鉴定
  • SNP基因晶片阵列
  • 其他的

第七章 市场区隔：依应用领域划分

  • 动物遗传学
  • 植物改良
  • 诊断调查
  • 药物和药物基因体学
  • 农业生物技术
  • 其他的

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：促进、抑制与机会

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Agilent Technologies Inc.
    • Eurofins Genomics（Eurofins Scientific SE）
    • Illumina Inc.
    • Integrated DNA Technologies, Inc.（Danaher Corporation）
    • LGC Limited
    • PREMIER Biosoft
    • Promega Corporation
    • QIAGEN NV
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A8146

The global single nucleotide polymorphism (SNP) genotyping market size reached USD 13.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 45.2 Billion by 2034, exhibiting a growth rate (CAGR) of 14.41% during 2026-2034. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET TRENDS:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

KEY MARKET SEGMENTATION:

Technology Insights:

  • TaqMan SNP Genotyping
  • Massarray SNP Genotyping
  • SNP GeneChip Arrays
  • Others

Application Insights:

  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc.(Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
  • What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
  • What are the key regional markets?
  • Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
  • Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 TaqMan SNP Genotyping
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Massarray SNP Genotyping
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 SNP GeneChip Arrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Animal Genetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plant Improvement
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceuticals and Pharmacogenomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Agricultural Biotechnology
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eurofins Genomics (Eurofins Scientific SE)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Illumina Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 LGC Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 PREMIER Biosoft
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Promega Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 QIAGEN N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Roche Holding AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2025
  • Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
  • Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Competitive Structure
  • Table 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Players